Skip to content
All products
Entering real-world validation

Breast-health awareness, screening support and navigation

Aloka Care

A Guiding Light — from the First Question to the Right Next Step.

Early awareness. Clearer next steps.

Every year, breast cancer takes thousands of Indian women — because it is caught too late. In a country this vast, most women will never reach a mammography centre in time.

Aloka Care exists to change that. It is a guiding light that carries structured breast-health screening the last mile — helping women recognise breast-health concerns, understand when further assessment is needed, and reach the right point of care sooner.

Laboratory performance

99.64%

Sensitivity (in-silico)

99.95%

Negative predictive value (in-silico)

Laboratory testing on synthetic data — 1.2 million simulated records. These are computational results, not clinical validation. Real-world clinical validation is the next step.

What it aims to do

  • A short, evidence-informed health check-in — about three minutes — that asks clear questions about breast symptoms and relevant history, in the user’s own language.
  • Every response is sorted by a deterministic, clinician-built rule engine into one of three pathways — Routine, Priority or Urgent — so the most concerning cases are seen first.
  • The woman sees only “Submitted for clinician review.” A doctor always decides.
  • Built to reach women in every Indian language through India’s Bhashini language ecosystem, and to work alongside the ASHA and community health workers who already reach women in their homes.

What sets it apart

  • Three-tier clinical triage: Routine, Priority, Urgent.
  • A doctor reviews and decides every case.
  • Multilingual by design for every Indian language.
  • Built for the last mile, alongside community health workers.

Our approach

Aloka Care is clinician-led by design: transparent, deterministic decision rules, defined red-flag pathways, privacy-conscious data handling, and a doctor in the loop for every case. Breast cancer is where we begin — the same platform is being built to support screening for more cancers, including cervical and oral cancer.

Where we are

  1. Clinical protocol & rule engine builtAchieved
  2. TRL 4 — laboratory validation completeAchieved
  3. Real-world validation with clinicians, patients and ASHA workersNext
  4. Scalable deployment once proven safe and reliableAhead
  5. Extension to cervical, oral and other cancersAhead

Aloka Care — a guiding light, from the first question to the right next step.